Squarepoint Ops LLC Galapagos Nv Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.5 - $48.0 $666,161 - $876,048	18,251 New	18,251 $705,000
Q2 2019 Aug 14, 2019	SELL	$111.45 - $128.93 $987,781 - $1.14 Million	-8,863 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $794,213 - $1.04 Million	8,863 New	8,863 $1.04 Million
Q4 2018 Feb 14, 2019	SELL	$87.81 - $110.65 $686,147 - $864,619	-7,814 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$90.63 - $120.22 $420,885 - $558,301	-4,644 Reduced 37.28%	7,814 $879,000
Q2 2018 Aug 14, 2018	BUY	$88.4 - $105.34 $199,607 - $237,857	2,258 Added 22.14%	12,458 $1.15 Million
Q1 2018 May 15, 2018	BUY	$94.51 - $120.23 $964,002 - $1.23 Million	10,200 New	10,200 $1.02 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.56B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.